Is This Perimenopause? Irregular Cycles, Mood Changes and Brain Fog Explained

Irregular Cycles, Mood Changes and Brain Fog Explained

The early signs of perimenopause rarely look like the menopause you were expecting. Here is what is actually happening in your body and why it starts earlier than most women are told.

You are in your early to mid-40s. Your cycle has shifted, shorter some months, longer others, occasionally arriving when you least expect it. You have been waking at 3 am for no clear reason. You do not feel like yourself in a way you cannot fully explain: irritable one day, low the next. You sit down to write something and the words do not come the way they used to.

You mention it to your GP. A blood test comes back normal. You are told it is probably stress.

It may not be stress. The most likely explanation is that the hormonal architecture of your cycle has begun to shift, quietly, gradually, and years before most women are told to expect it. This is perimenopause.

Its earliest signs are not the dramatic hot flushes most people associate with menopause. They are cycle changes, cognitive shifts, sleep disruption, and mood volatility,  symptoms that are easy to misattribute, but which have a specific and well-understood biological origin.

Understanding that origin changes what you can do about it.

Irregular Cycle in Your 40s: The First Sign Most Women Miss

An irregular cycle in your 40s  or a cycle that has become shorter than usual is one of the earliest signs of perimenopause, and one of the most commonly overlooked.

The menopause transition does not begin with oestrogen falling. It begins with a decline in inhibin B - a hormone produced by the granulosa cells of small antral follicles in the ovary. Inhibin B suppresses FSH (Follicle-stimulating hormone) from the pituitary. As the ovarian follicle pool shrinks with age, inhibin B decreases, FSH rises, and folliculogenesis accelerates. Research shows that this causes the follicular phase of the menstrual cycle to shorten: the dominant follicle matures more quickly, ovulates earlier, and the overall cycle compresses. A woman who has had 28-day cycles for years may notice they have become 24 or 25 days, a shorter cycle than usual that appears before any other perimenopause symptoms.

This is measurable. A 2021 review in the Journal of Clinical Endocrinology and Metabolism confirmed that the perimenopause is characterised by wide hormonal fluctuations and irregular menstrual patterns driven by the gradual loss of oocytes and altered responsiveness to gonadal steroid feedback, a disruptive process that can last over a decade and produces measurable cycle changes years before the final menstrual period.

As the transition progresses, cycles can shift in the opposite direction too: longer, skipped, or wildly variable. This reflects an increasing proportion of anovulatory cycles in which a follicle develops but does not release an egg. Without ovulation, there is no progesterone, oestrogen goes unopposed, and the endometrium continues to thicken before shedding in a heavier or delayed bleed.

A single FSH or oestradiol reading at this stage is unlikely to tell the full story. Studies confirm that there is no reliable single endocrine marker of early perimenopause: FSH fluctuates dramatically from cycle to cycle, and oestradiol in early perimenopause is often higher than in younger women. Cycle pattern history is more diagnostically useful than a snapshot blood test.

What this means: A cycle that has become consistently shorter than usual, or that has started varying by more than seven days each month, is among the earliest signs of perimenopause, often appearing years before periods become markedly irregular or stop. It is not a reason to dismiss the possibility because a single blood test was normal.

Mood Swings Before Menopause: The Progesterone-GABA Connection

Mood swings before menopause are one of the most frequently misunderstood early signs of perimenopause. They often predate cycle irregularity by years, and they are routinely attributed to stress, anxiety, or a depressive episode, when the cause is neurobiological.

The mechanism involves two parallel hormonal pathways that begin shifting with the hormonal changes at 40.

The first is progesterone’s relationship with the GABA system. Progesterone is metabolised in the brain into allopregnanolone: a neurosteroid that directly enhances GABA-A receptor activity, the brain’s primary inhibitory system. Allopregnanolone produces anxiolytic, sedative, and mood-stabilising effects that are pharmacologically similar to benzodiazepines. As progesterone begins to fall, especially during anovulatory cycles (cycles without ovulation), when it may not be produced at all, this GABAergic calming effect is reduced or absent.

Research on cognition, mood and sleep in the menopausal transition confirms that progesterone and allopregnanolone promote GABAergic inhibition throughout the brain, producing anxiolytic effects, and that decreased allopregnanolone levels are directly associated with depression and anxiety. The restoration of progesterone is associated with clinical improvement in these symptoms.

The second pathway involves oestrogen and serotonin. Oestrogen modulates serotonin receptor density, binding, and transport in the prefrontal cortex and hippocampus the regions governing mood, motivation, and emotional regulation.

Research published in Frontiers in Pharmacology documents that oestrogen decline is associated with impaired serotonin signalling, downstream disruption of the dopaminergic system, and neurochemical instability that contributes to depression, irritability, and anxiety. These effects are not limited to postmenopause: they begin during the hormonal fluctuations of the perimenopause transition.

The mood swings before menopause that women describe are typically cyclical: worst in the luteal phase, tied to the days before a period, and characterised by irritability and low frustration tolerance rather than persistent low mood. This is a biological signature, not a psychiatric diagnosis. It is the withdrawal pattern of two neurosteroids that have been modulating the brain’s calming systems for decades.

What this means: Mood swings, irritability, or anxiety that began in your 40s, intensify before your period, and feel different from your previous emotional baseline are likely early signs of perimenopause. They are not a mood disorder, but the neurobiological effects of falling progesterone on the GABA system and oestrogen on serotonin.

Brain Fog in Perimenopause: Why Your Mind Feels Different

Brain fog in perimenopause is the experience of word-finding difficulty, poor working memory, reduced concentration, and mental fatigue, which is reported by an estimated 40 to 60% of women during the menopause transition. Longitudinal studies, including the SWAN cohort, find small but statistically reliable declines in objective memory performance as women transition into perimenopause, independent of ageing alone.

The mechanism is oestrogen’s role in brain bioenergetics. Oestrogen is not only a reproductive hormone. It is a neuroactive steroid with receptors distributed throughout the brain, including the hippocampus and prefrontal cortex. One of its key functions is maintaining the brain’s glucose metabolism — regulating how efficiently neurons access and use their primary fuel source.

Research using multi-modality neuroimaging in women at different stages of the menopause transition found that glucose metabolism starts declining during perimenopause and continues into postmenopause, associated with reductions in grey and white matter volume and early amyloid-beta deposition in Alzheimer ’s-vulnerable regions. These changes were most pronounced during the transition itself and were not explained by age alone.

A 2024 review confirmed that this cerebral glucose hypometabolism is likely driven in part by oestrogen’s role in brain bioenergetics and the widespread expression of oestrogen receptors throughout the brain. When oestrogen fluctuates unpredictably, neural energy supply becomes erratic, which directly produces the cognitive symptoms women describe as brain fog in perimenopause.

This is not anxiety. It is not early dementia. In most women, cognitive function stabilises and improves after the transition. But for women navigating demanding work and personal lives, the interim disruption is real, measurable, and consistently undiscussed by healthcare providers.

What this means: Brain fog in perimenopause that begins in the early-to-mid 40s, presenting as word-finding difficulty, poor working memory, reduced concentration, and mental fatigue, reflects oestrogen’s declining effect on brain glucose metabolism. It is a neurological event, not a psychiatric symptom, and it does not signal dementia.

Sleep Problems in Your 40s and Night Sweats Before Menopause: What Is Actually Happening

Sleep problems in women in their 40s are among the most common early signs of perimenopause, and night sweats before menopause arrive earlier than most women expect, often years before periods stop.

Night sweats are triggered by the hypothalamic thermoregulatory centre, the brain’s internal thermostat. Oestrogen regulates the ‘thermoneutral zone’: the range of core body temperature within which neither sweating nor shivering is triggered. As oestrogen begins to fluctuate and decline, this zone narrows, so that minor rises in core temperature that would previously have been tolerated now trigger disproportionate heat-loss responses: peripheral vasodilation, sweating, and the sensation of a hot flush. The mechanism is now well understood: oestrogen withdrawal leads to hyperactivation of KNDy neurons (kisspeptin, neurokinin B, dynorphin) in the hypothalamic arcuate nucleus, which in turn disrupts the thermoregulatory pathways of the preoptic area. A 2025 review of neurokinin B signalling in vasomotor symptoms confirmed that this KNDy neuron hyperactivation, directly driven by oestrogen withdrawal, is the key mechanism underlying hot flushes and night sweats, and has led to the first non-hormonal treatment specifically targeting this pathway.

Sleep disruption in perimenopausal women runs deeper than the night sweats themselves. A 2025 narrative review on sleep disturbance and perimenopause found that fluctuations in both oestrogen and progesterone affect sleep quality through multiple parallel mechanisms: vasomotor disruption, reduced GABAergic sedation from falling progesterone, rising FSH directly linked to wakefulness after sleep onset, reduced slow-wave sleep, and increased nocturnal cortisol. Many perimenopausal women have sleep problems that precede or occur independently of night sweats.

The autonomic dimension is significant. The sympathetic nervous system, the biological ‘alert’ state, becomes relatively dominant during perimenopause as both oestrogen and progesterone withdrawal increase norepinephrine activity. This is why sleep problems in women in their 40s often present as early waking rather than difficulty falling asleep: the nervous system is not switching fully into the parasympathetic rest state at night. The 3am waking that many perimenopausal women describe is this autonomic shift made visible.

Research on vasomotor symptoms and autonomic dysfunction has further linked this autonomic dysregulation to elevated cardiovascular risk, confirming that night sweats before menopause and the associated sleep disruption are not merely quality-of-life issues but early markers of a shifting cardiometabolic risk profile.

What this means: Sleep problems in your 40s, particularly early-morning waking, lighter and less restorative sleep, and night sweats before menopause,  are early signs of perimenopause driven by the convergence of hypothalamic thermoregulation changes, falling progesterone, rising FSH, and autonomic nervous system shifts. They precede, in most women, any change in cycle pattern.

Hormonal Changes at 40: Why Perimenopause Starts Earlier Than You Were Told

The popular narrative positions menopause as a mid-50s event. The hormonal changes at 40 that precede it are almost never part of that conversation.

A 2021 review in the Journal of Clinical Endocrinology and Metabolism confirmed that the menopausal transition is a disruptive process lasting over a decade in many women, with measurable hormonal and cycle changes beginning well before periods become visibly irregular, and that it is important for clinicians to recognise early signs and symptoms of the transition and be prepared to offer treatment. Some research suggests FSH elevation, the earliest hormonal change in the transition, can be present a decade before the final menstrual period in some women.

This matters for two reasons.

First, the early signs of perimenopause that arrive with the hormonal changes at 40, a shorter cycle than usual, mood swings before menopause, brain fog in perimenopause, sleep problems, night sweats before menopause,  are rarely recognised as hormonal. The result is that symptoms are attributed to stress, burnout, depression, or ‘just getting older’ and the underlying biology goes unaddressed.

Second, the interventions that matter most, whether nutritional, lifestyle-based, or hormonal, are substantially more effective when introduced early in the transition, before the hormonal environment has changed significantly. 

The perimenopausal window is not a waiting room for menopause. It is a period of active biological change with real clinical relevance.

The symptoms in this article are not separate, unrelated experiences. An irregular cycle in your 40s, mood swings before menopause, brain fog in perimenopause, sleep problems, and night sweats before menopause are all expressions of the same hormonal transition. They have the same origin: the gradual shift in ovarian signalling that begins, in most women, well before the age at which perimenopause is culturally expected.

What this means: If you are experiencing hormonal changes at 40, a shorter cycle than usual, mood swings, brain fog, sleep problems, or night sweats before menopause, these are early signs of perimenopause and they deserve a clinical explanation, not a dismissal.

The Transition Starts Quietly. That Does Not Mean It Should Go Unaddressed.

Perimenopause is not a disease. It is a biological transition that every woman who lives long enough will experience. But the way it unfolds, how symptomatic it is, how long it lasts, what it costs in terms of cognitive function, sleep quality, mood stability, and long-term health, is not fixed.

The early signs of perimenopause described here are each rooted in well-characterised biology. An irregular cycle in your 40s. A shorter cycle than usual. Mood swings before menopause. Brain fog in perimenopause. Sleep problems in your 40s. Night sweats before menopause. Hormonal changes at 40 that feel hard to name. Each one is measurable, explainable, and responsive to the right support.

The earlier this process is understood, the more effectively it can be navigated. The next step is not to wait for your cycles to stop. It is to understand what is already shifting, and to build the picture clearly enough to act on it.

‍